CR06939-2014

SECURITIES AND EXCHANGE COMMISSIONSEC FORM 17-Q

QUARTERLY REPORT PURSUANT TO SECTION 17 OF THE SECURITIES
REGULATION CODE AND SRC RULE 17(2)(b) THEREUNDER

1. For the quarterly period ended
Sep 30, 2014
2. SEC Identification Number
39652
3. BIR Tax Identification No.
004-844-938-000
4. Exact name of issuer as specified in its charter
MEDCO HOLDINGS, INC.
5. Province, country or other jurisdiction of incorporation or organization
METRO MANILA, PHILIPPINES
6. Industry Classification Code(SEC Use Only)
7. Address of principal office
31st FLOOR RUFINO PACIFIC TOWER 6784 AYALA AVENUE, MAKATI CITY Postal Code 1229
8. Issuer's telephone number, including area code
632-8110465
9. Former name or former address, and former fiscal year, if changed since last report
-
10. Securities registered pursuant to Sections 8 and 12 of the SRC or Sections 4 and 8 of the RSA
Title of Each Class Number of Shares of Common Stock Outstanding and Amount of Debt Outstanding
COMMON SHARES 700,000,000
11. Are any or all of registrant's securities listed on a Stock Exchange?
Yes
No
If yes, state the name of such stock exchange and the classes of securities listed therein:
PHILIPPINE STOCK EXCHANGE, INC. / COMMON SHARES
12. Indicate by check mark whether the registrant:

(a) has filed all reports required to be filed by Section 17 of the SRC and SRC Rule 17 thereunder or Sections 11 of the RSA and RSA Rule 11(a)-1 thereunder, and Sections 26 and 141 of the Corporation Code of the Philippines, during the preceding twelve (12) months (or for such shorter period that the registrant was required to file such reports)

Yes
No
(b) has been subject to such filing requirements for the past ninety (90) days
Yes
No

The Exchange does not warrant and holds no responsibility for the veracity of the facts and representations contained in all corporate disclosures, including financial reports. All data contained herein are prepared and submitted by the disclosing party to the Exchange, and are disseminated solely for purposes of information. Any questions on the data contained herein should be addressed directly to the Corporate Information Officer of the disclosing party.

MEDCO Holdings, Inc.MED

PSE Disclosure Form 17-2 - Quarterly Report References: SRC Rule 17 and
Sections 17.2 and 17.8 of the Revised Disclosure Rules

For the period ended Sep 30, 2014
Currency (indicate units, if applicable) PHIL. PESO
Balance Sheet
Period Ended
Fiscal Year Ended (Audited)
Sep 30, 2014 Dec 31, 2013
Current Assets 9,622,816 12,343,189
Total Assets 41,510,904 44,127,242
Current Liabilities 201,404,012 197,336,422
Total Liabilities 204,492,918 201,139,484
Retained
Earnings/(Deficit)
-858,504,655 -854,363,896
Stockholders' Equity -162,982,014 -157,012,242
Stockholders' Equity - Parent -135,548,042 -131,407,283
Book Value per Share -0.19 -0.18
Income Statement
Current Year
(3 Months)
Previous Year
(3 Months)
Current Year-To-Date
Previous Year-To-Date
Operating Revenue - - - -
Other Revenue 391 25,233 2,404,771 94,023
Gross Revenue 391 25,233 2,404,771 94,023
Operating Expense 2,647,298 3,225,014 8,374,543 10,429,593
Other Expense - - - -
Gross Expense 2,647,298 3,225,014 8,374,543 10,429,593
Net Income/(Loss) Before Tax -2,042,691 -2,506,888 -4,140,759 -8,316,934
Income Tax Expense - - - -
Net Income/(Loss) After Tax -2,042,691 -2,506,888 -4,140,759 -8,316,934
Net Income Attributable to
Parent Equity Holder
-2,042,691 -2,506,888 -4,140,759 -8,316,934
Earnings/(Loss) Per Share
(Basic)
-0 -0 -0 -0.01
Earnings/(Loss) Per Share
(Diluted)
-0 -0 -0 -0.01
Other Relevant Information

QUARTERLY REPORT - SEPTEMBER 30, 2014

Filed on behalf by:
Name Mary Ann Miel
Designation Chief Accountant